← Home
/
ARS Pharmaceuticals, Inc. (SPRY)
Stock Analysis
ARS Pharmaceuticals, Inc. (SPRY)
SPRY
SPRY · Market data
9.73
-1.77%
Updated: 2026-06-18 18:29 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 9.78. Holding above 9.38 keeps the current thesis intact.
✓
Fundamentals
Strong / Negative
✓
Price Structure
Constructive
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
9.38
↗
Break Above
Confirmation improves above resistance.
9.78
🎯
Next Objective
Pattern-derived target if setup continues.
12.11
×
Thesis Break
Scenario weakens below invalidation.
Below 9.38
What's Driving SPRY?
📈 Technical recovery is improving
Momentum is Neutral. Watch 9.78 for confirmation and 9.38 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 8.84 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression / SYM / UP
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 8.84 and resistance at 9.79. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 6.82; losing that area would weaken the active formation considerably.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
💵 Revenue
22.68M
↗ Strong
📈 Net Income
-60.62M
↘ Negative
🧮 EPS (Basic)
-0.61
↘ Negative
ARS Pharmaceuticals, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.